Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples

Researchers have developed a computational framework to analyze 'gene mutant dosage' (GMD) in cancer samples, identifying 46 biomarkers that predict patient survival and metastatic behavior. This method provides deeper insights into tumor evolution than traditional binary mutation models.